J&J Aims For High-Growth Areas With New Collaborations
Pharma & Healthcare / United States / Sat 24 Jun, 2017
Johnson & Johnson's latest collection of agreements span its medical device and pharmaceutical units, highlighting the synergies here. The collaborations are all at an early stage, and are in high-growth markets and the technologies sector which should serve to maintain the position J&J currently has in orthopaedic devices and immunology drugs, and